Cognitive functions in long-term survivors of ovarian cancer Journal Article
| Authors: | Correa, D. D.; Zhou, Q.; Thaler, H. T.; Maziarz, M.; Hurley, K.; Hensley, M. L. |
| Article Title: | Cognitive functions in long-term survivors of ovarian cancer |
| Abstract: | Background: Women diagnosed with ovarian cancer often undergo chemotherapy involving multiple agents. However, little is known about the incidence of cognitive adverse effects of chemotherapy in survivors of this disease. This cross-sectional study assessed neuropsychological functions in long-term survivors of ovarian cancer who were either in complete remission or with evidence of recurrent disease. Methods: Forty-eight women diagnosed with ovarian cancer 5 to 10 years prior to study enrollment underwent a brief neuropsychological evaluation; 22 patients were disease free and without history of recurrence (Group 1), and 26 patients had recurrent disease and were receiving treatment with chemotherapy or hormonal therapy (Group 2). Results: There were no statistically significant differences between the two patient groups on tests of attention, memory, and executive functions. Group mean cognitive test scores were within the average range on all tests; however 28% of patients met criteria for cognitive impairment, a significantly higher frequency (p = 0.03) than reported in healthy populations. Conclusions: In this study, neuropsychological test performance did not differ significantly between ovarian cancer survivors who were in remission and patients with recurrent disease and receiving treatment. Cognitive impairment was evident in a subset of patients, although group means test scores were within the average range. Additional research using prospective longitudinal designs is needed to clarify the contribution of disease, chemotherapy, hormonal therapy, and other risk factors to cognitive outcome in this clinical population. © 2010 Elsevier Inc. All rights reserved. |
| Keywords: | adult; clinical article; controlled study; aged; aged, 80 and over; middle aged; cancer recurrence; cisplatin; antineoplastic agents; paclitaxel; ovarian cancer; ovarian neoplasms; carboplatin; quality of life; ovary cancer; cancer survivor; survivors; cancer regression; neuropsychological test; neuropsychological tests; cognition; cognitive defect; cross-sectional studies; cognitive; cognition disorders; memory; attention; neuropsychology; chemotherapy adverse effects |
| Journal Title: | Gynecologic Oncology |
| Volume: | 119 |
| Issue: | 2 |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2010-11-01 |
| Start Page: | 366 |
| End Page: | 369 |
| Language: | English |
| DOI: | 10.1016/j.ygyno.2010.06.023 |
| PUBMED: | 20630576 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 20 April 2011" - "CODEN: GYNOA" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work